Zacks Investment Management Verrica Pharmaceuticals Inc. Transaction History

Zacks Investment Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$7.41 - $12.63 $267,063 - $455,197	-36,041 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$6.16 - $10.3 $7,909 - $13,225	-1,284 Reduced 3.44%	36,041 $279,000
Q2 2020 Aug 14, 2020	SELL	$9.02 - $15.12 $7,225 - $12,111	-801 Reduced 2.1%	37,325 $411,000
Q4 2019 Feb 14, 2020	BUY	$13.08 - $17.43 $498,688 - $664,536	38,126 New	38,126 $606,000

17.4M

6.1K

6.3K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.